Skip to main content
. Author manuscript; available in PMC: 2013 Aug 29.
Published in final edited form as: Gynecol Oncol. 2009 Jul 3;115(1):135–137. doi: 10.1016/j.ygyno.2009.06.012

Table 1.

Comparison of case and control subjects.

Variables Controls N = 560 Cases N = 154 P value
Date of birth (range) 1946.7 (1916–68) 1947.2 (1919–66) 0.62
Diagnosis of breast cancer (range)
 Year 1989.2 (1953–07) 1989.1 (1957–05) 0.96
 Age 43.0 (26–68) 42.5 (27–66) 0.53
Chemotherapy 61.6% 66.8% 0.29
Radiotherapy 46.5% 50.7% 0.42
Type of surgery Mastectomy 63.3% 66.2% 0.57
Ovarian cancer diagnosis (range)
 Year N/A 1998.2 (1978–08) N/A
 Age N/A 51.4 (35–75) N/A
Tamoxifen treatment 20.7% 20.1% 0.89
Oral contraceptive use 55.5% 53.2% 0.67
Hormone replacement therapy 6.5% 4.6% 0.39
Parity
 Mean (range) 2.2 (0–8) 2.0 (0–7) 0.16
 Nulliparity 11.3% 13.6% 0.50

All p values were derived using the Student’s t test for continuous variables and the chi-square test for categorical variables.